home

Company Releases Financial Releases Product Releases Archived Releases2015201420132012201120102009200820072006 Media Inquiries Fact Sheets Email Alerts Significant Improvements in Skeletal Mineralization and Physical Function Observed in Children with Hypophosphatasia (HPP) Treated With Strensiq™ (asfotase alfa) Sustained for at least Five Years